Table: begin end state 1 25 cytoplasmic 26 51 transmembrane 52 57 non-cytoplasmic 58 78 transmembrane 79 88 cytoplasmic 89 108 transmembrane 109 119 non-cytoplasmic 120 137 transmembrane 138 143 cytoplasmic 144 163 transmembrane 164 187 non-cytoplasmic 188 210 transmembrane 211 276 cytoplasmic 277 302 transmembrane 303 311 non-cytoplasmic 312 332 transmembrane 333 334 non-cytoplasmic 335 352 cytoplasmic 353 354 non-cytoplasmic 355 401 transmembrane 402 406 cytoplasmic 407 426 transmembrane 427 427 cytoplasmic 428 431 non-cytoplasmic 432 450 transmembrane 451 468 cytoplasmic 469 495 transmembrane 496 503 non-cytoplasmic 504 525 transmembrane 526 527 non-cytoplasmic 528 530 cytoplasmic 531 551 transmembrane 552 554 cytoplasmic 555 576 transmembrane 577 586 non-cytoplasmic 587 607 transmembrane 608 618 cytoplasmic 619 644 transmembrane 645 655 non-cytoplasmic 656 683 transmembrane 684 698 cytoplasmic
Input: >AZOBR_RS08575 FitnessBrowser__azobra:AZOBR_RS08575 MSASPQEADNKIRQAIDRENPSTVVAFEGVAGKAVFAIAVAFSLFQIWTAAFNPLSSMVV RSVHVGFLLLMTFTLFGFRQEAERRSVPWYDWLLGLGAFALGLYHYVFEVDLIQRAGDPN TTDLIVGALTIALVFEAARRIMGWALPIMCGVFIPYALFGRHLPFGLAHRGYDVDQVIDN LYLSTEGIYGTPTFVSATFIFLFILFGAFLERAGMIKLFNDVSLGLVGHAKGGPAKVAVI SSGFMGTINGSGVANVLTTGQFTIPLMMRFGYRPAFAGAVEATASMGGQIMPPVMGAAAF IMAETIGVPFSDIAIAAAIPAILYFGSAFWMVHLEAGKHNLVGLPKDQCPSVLGALKESW YLILPLAALVYLLFSGFTPLFAGVIGIALTVALILGTRIVGFIGPTALRVGFWVVLGLIA AALWRMGLRTEHLAFAIVGLLVLPCLALKGGRETLALLVQSLADGAKNAVGVGVACALVG VLIGILTLTGLASSFASTIMDLSGGNLLIALLLTMLACIVLGTGLPTTANYIITAAIAAP ALLQMGVPLIVSHMFVFYFGIMADLTPPVALAALAASSICRAGHMEIGWIATRVAMAGYV VPFMAVYDPALMLQTDDPLAVAYVLFKALISIGLWGAATIGYFWTPMNWAERVFAAAAAF LFVLSLPVTDEAGFVMTAAFLLWQRHRLRRLGRTSAPA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server